Early Versus Late Injection Laryngoplasty for Unilateral Vocal Fold Paralysis.

Authors

Ahmed S Abdelmeguid, Mohamed Y Elkotb, Hemmat Baz, Abdelrahman A Kamal

Published in

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery. Oct 11, 2026. Epub Oct 11, 2026.

Abstract

Unilateral vocal fold paralysis (UVFP) is a condition characterized by the loss of functional movement of one vocal fold resulting in incomplete glottic closure, which compromises essential functions such as phonation, swallowing and coughing. Injection medialization laryngoplasty can temporarily restore glottic closure, improving voice quality and potentially reducing the risk of aspiration.
A prospective cohort study was conducted from September 2024 to January 2026. Patients with UVFP were divided into early (< 6 months from the onset of paralysis) and late (≥ 6 months). All patients received injection medialization using hyaluronic acid (Perfectha Derm, 20 mg/mL). This was done either under local anaesthesia or under general anaesthesia. Voice assessment was done before injection and at 1 and 6 months post-injection, including maximum phonation time (MPT), GRBAS, acoustic analysis (jitter, shimmer, HNR) using PRAAT and patient-reported Arabic Voice Handicap Index (VHI).
Forty-eight patients with UVFP were enrolled and divided into early (< 6 months) and late (≥ 6 months) groups. The early injection group showed significantly higher MPT at 1 week and 6 months. Fewer patients required Type I thyroplasty in the early injection group compared to patients who underwent later injection (p = 0.001). Long-term acoustic measures were also superior in the early group, indicating better voice quality.
Early injection laryngoplasty was associated with superior long-term voice outcomes and a significantly reduced need for permanent medialization surgery compared with late injection. These findings highlight the clinical importance of early intervention in the management of UVFP.

PMID:
42860243
Bibliographic data and abstract were imported from PubMed on 12 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.